Cytokinetics, Inc. (CYTK)
56.16
-2.37
(-4.05%)
USD |
NASDAQ |
Nov 12, 16:00
56.00
-0.16
(-0.28%)
After-Hours: 06:15
Cytokinetics Profit Margin (Quarterly) : -399.7% for Sept. 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -399.7% |
| June 30, 2026 | -694.4% |
| March 31, 2026 | -1.06K% |
| December 31, 2025 | -1.03K% |
| September 30, 2025 | -15.81K% |
| June 30, 2025 | -201.2% |
| March 31, 2025 | -10.22K% |
| December 31, 2024 | -886.3% |
| September 30, 2024 | -34.67K% |
| June 30, 2024 | -57.56K% |
| March 31, 2024 | -16.24K% |
| December 31, 2023 | -8.19K% |
| September 30, 2023 | -34.24K% |
| June 30, 2023 | -14.84K% |
| March 31, 2023 | -2.85K% |
| December 31, 2022 | -7.02K% |
| September 30, 2022 | -5.66K% |
| June 30, 2022 | -22.28% |
| March 31, 2022 | -7.79K% |
| December 31, 2021 | -54.98% |
| September 30, 2021 | -1.40K% |
| June 30, 2021 | -2.17K% |
| March 31, 2021 | -719.4% |
| December 31, 2020 | -653.5% |
| September 30, 2020 | -7.62% |
| Date | Value |
|---|---|
| June 30, 2020 | -1.13K% |
| March 31, 2020 | -1.03K% |
| December 31, 2019 | -587.9% |
| September 30, 2019 | -488.4% |
| June 30, 2019 | -450.0% |
| March 31, 2019 | -347.0% |
| December 31, 2018 | -282.3% |
| September 30, 2018 | -206.9% |
| June 30, 2018 | -442.8% |
| March 31, 2018 | -574.8% |
| December 31, 2017 | |
| September 30, 2017 | -523.6% |
| June 30, 2017 | -952.5% |
| March 31, 2017 | -622.9% |
| December 31, 2016 | 21.60% |
| September 30, 2016 | 56.50% |
| June 30, 2016 | -200.1% |
| March 31, 2016 | -147.9% |
| December 31, 2015 | -94.59% |
| September 30, 2015 | -111.4% |
| June 30, 2015 | -161.3% |
| March 31, 2015 | -201.0% |
| December 31, 2014 | 38.80% |
| September 30, 2014 | -63.42% |
| June 30, 2014 | -107.5% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| BridgeBio Pharma, Inc. | -17.13% |
| Alnylam Pharmaceuticals, Inc. | -- |
| BioMarin Pharmaceutical, Inc. | -11.99% |
| Exelixis, Inc. | 33.11% |
| Ionis Pharmaceuticals, Inc. | -45.31% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -49.33% |
| Return on Invested Capital | -102.1% |
| Gross Profit Margin (Quarterly) | 87.67% |
| Operating Margin (Quarterly) | -351.3% |
| Return on Net Operating Assets | -456.9% |